<DOC>
	<DOCNO>NCT00628758</DOCNO>
	<brief_summary>The primary objective compare efficacy Symbicort Single inhaler Therapy treatment accord conventional best practice adult patient persistent asthma .</brief_summary>
	<brief_title>A Comparison SymbicortÂ® Single Inhaler Therapy Conventional Best Practice Treatment Persistent Asthma</brief_title>
	<detailed_description>A secondary objective collect safety data treatment wtih Symbicort Single inhaler Therapy adult patient persistent asthma .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Signed informed consent form . If patient read write , verbal consent patient require . Ability read write Turkish Female male outpatient age 18 year Minimum 3 month history asthma , diagnose accord American Thoracic Society ( ATS ) definition Prescribed inhale glucocorticosteroid ( GCS ) dose 320mg/day within approve label relevant drug last 3 month prior Visit 1 Either : daily maintenance treatment inhale GCS longacting b2agonist ( LABA ) daily treatment inhaled GCS alone ( i.e . without LABA ) ; history suboptimal asthma control month prior enrollment judge investigator ; use 3 Peak Expiratory Flow inhalation ofas need medication symptom relief last 7 day enrollment Previous treatment Symbicort Single inhaler Therapy Use bblocking agent , include eye drop Use oral GCS maintenance treatment Known suspect hypersensitivity study therapy excipients A history smoke 10 pack year Pregnancy , breastfeed plan pregnancy study . Fertile woman use acceptable contraceptive measure , judge investigator Any significant disease disorder , , opinion investigator , may put patient risk participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Symbicort</keyword>
	<keyword>Turbuhaler</keyword>
	<keyword>Persistent Asthma</keyword>
</DOC>